Evaluating the SWW Method® Dietary Intervention for HbA1c and Weight Management as a Preventive Intervention in Women

Background Individuals with elevated blood glucose markers and an unhealthy BMI are more at risk for type II diabetes, cardiovascular disease, and metabolic syndrome. Yet, most diets addressing this are not sustainable and are typically only implemented in an unhealthy population rather than functioning as a preventative measure. There is a notable gap in dietary interventions designed for generally healthy populations seeking to optimize metabolic health before disease onset. We conducted a case-control trial to determine if the SWW Method® was an effective intervention to help lower blood glucose and weight in a healthy cohort of women aged 35–75 (baseline HbA1c: 5.31–5.4%, BMI: 23–25). The SWW Method® is a carbohydrate-insulin model dietary and lifestyle intervention. Method: We recruited 45 SWW Method® participants and 40 comparable controls. All participants completed the same questionnaire and lab testing at the start and end of the 12-week study. Results: The intervention group’s HbA1cs improved significantly (5.4% to 5.33%) compared to the control group (5.31% to 5.4%) (p < 0.05). Yet, there was no significant change in fasting blood glucose. The SWW Method® group also experienced a reduction in BMI (p < 0.0001) and weight (p < 0.0001) over the course of the 12 weeks, but not in comparison to the controls, who also lost weight. Conclusion: Integrating the SWW Method® is moderately effective in improving HbA1c and in supporting weight loss within the intervention group, indicating its potential as a preventative health intervention for optimizing metabolic health in an already healthy population. Trial Registration ClinicalTrials.gov, NCT07463417, retrospectively registered March 5, 2026. Trial registration ClinicalTrials.gov, NCT07463417, retrospectively registered March 5, 2026